Uploaded June 2025 | Updated September 2026, 2 weeks ago
#cancer #science #data #biology #bioinformatics
In this video, I talk to Vineet Bafna about his current research on cancer. He talks about extrachromosomal DNA formation and the future of cancer research.
Vineet Bafna, Ph.D, is a Bioinformatics researcher, a Professor of Computer Science & Engineering and the HDSI Chancellor's Endowed Chair III of the Halicioglu Data Science Institute Data Science Institute at UC San Diego. He received his Ph.D. in computer science from The Pennsylvania State University in 1994 working on theoretical problems in genome rearrangements. His introduction of the breakpoint graph as an analytical tool has been an important driver of the field. After an NSF funded postdoctoral research at the Center for Discrete Mathematics and Theoretical Computer Science, Bafna was a senior investigator at SmithKline Beecham, conducting research on DNA signaling, target discovery and EST assembly. From 1999 to 2002, he worked at Celera Genomics, ultimately as Director of Informatics Research, participating in the assembly and annotation of the human genome. At UC San Diego, Bafna served as co-Director of the Bioinformatics and Systems Biology Ph.D. program from 2013-19 and was a founding faculty of the Halicioglu Data Science Institute at UCSD.
Vineet Bafna’s research focuses on cancer genomics and population genetics. He has made important contributions in identifying the mechanisms of complex rearrangements in cancer, including breakage fusion bridge cycles, extrachromosomal DNA, in population genetics on identifying the genetic signals of adaptation, analyzing experimental evolution, and proteogenomics. He has co-authored over 200 research articles in the leading journals in the field, including test-of-time awards at the International conference on Research Computational Molecular Biology (RECOMB) and at the European Symposium of Algorithms (ESA). He has co-founded two companies: Abterra, LLC, which focuses on services and products relating to proteogenomic data, and Boundless Bio, Inc., which is targeting extrachromosomal DNA in cancer, and was listed as a public company in 2024. Bafna is a fellow of the International Society of Computational Biology (2019) and an ACM fellow (2023).
#cancer #science #data #biology #bioinformatics
In this video, I talk to Vineet Bafna about his current research on cancer. He talks about extrachromosomal DNA formation and the future of cancer research.
Vineet Bafna, Ph.D, is a Bioinformatics researcher, a Professor of Computer Science & Engineering and the HDSI Chancellor's Endowed Chair III of the Halicioglu Data Science Institute Data Science Institute at UC San Diego. He received his Ph.D. in computer science from The Pennsylvania State University in 1994 working on theoretical problems in genome rearrangements. His introduction of the breakpoint graph as an analytical tool has been an important driver of the field. After an NSF funded postdoctoral research at the Center for Discrete Mathematics and Theoretical Computer Science, Bafna was a senior investigator at SmithKline Beecham, conducting research on DNA signaling, target discovery and EST assembly. From 1999 to 2002, he worked at Celera Genomics, ultimately as Director of Informatics Research, participating in the assembly and annotation of the human genome. At UC San Diego, Bafna served as co-Director of the Bioinformatics and Systems Biology Ph.D. program from 2013-19 and was a founding faculty of the Halicioglu Data Science Institute at UCSD.
Vineet Bafna’s research focuses on cancer genomics and population genetics. He has made important contributions in identifying the mechanisms of complex rearrangements in cancer, including breakage fusion bridge cycles, extrachromosomal DNA, in population genetics on identifying the genetic signals of adaptation, analyzing experimental evolution, and proteogenomics. He has co-authored over 200 research articles in the leading journals in the field, including test-of-time awards at the International conference on Research Computational Molecular Biology (RECOMB) and at the European Symposium of Algorithms (ESA). He has co-founded two companies: Abterra, LLC, which focuses on services and products relating to proteogenomic data, and Boundless Bio, Inc., which is targeting extrachromosomal DNA in cancer, and was listed as a public company in 2024. Bafna is a fellow of the International Society of Computational Biology (2019) and an ACM fellow (2023).
